rxstatShortages › Ceftriaxone

Ceftriaxone shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ceftriaxone products are in shortage in Canada (1 of 15 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 15, 2026.
Products affected
1 of 15
Est. full return
Jun 15, 2026
Reports on file
42
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
CEFTRIAXONE FOR INJECTION
100G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02409968 · since ?, est. end Jun 15, 2026 · Other (Please describe in comments)
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
2G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02292289 · ended Apr 20, 2026 · Disruption of the manufacture of the drug.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
10G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02292297 · ended Apr 20, 2026 · Demand increase for the drug.
Resolved
CEFTRIAXONE INJECTION, USP
2000MG · SOLUTION · BAXTER CORPORATION
DIN 02499738 · ended Feb 20, 2026 · Delay in shipping of the drug.
To be discontinued
CEFTRIAXONE SODIUM FOR INJECTION BP
250MG · POWDER FOR SOLUTION · STERIMAX INC
DIN 02325594
Discontinued
CEFTRIAXONE SODIUM FOR INJECTION
10G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02287668
Discontinued
CEFTRIAXONE SODIUM FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02287633
Resolved
CEFTRIAXONE INJECTION, USP
2000MG · SOLUTION · BAXTER CORPORATION
DIN 02499738 · ended Jan 31, 2025 · Disruption of the manufacture of the drug.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
1G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02325616 · ended Dec 19, 2024 · Delay in shipping of the drug.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
2G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02325624 · ended Dec 19, 2024 · Delay in shipping of the drug.
Resolved
CEFTRIAXONE INJECTION, USP
1000MG · SOLUTION · BAXTER CORPORATION
DIN 02499711 · ended Aug 23, 2024 · Shortage of an inactive ingredient or component.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
250MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02292262 · ended Jan 8, 2024 · Demand increase for the drug.

Showing 12 of 42 reports. All reports are on file with Health Canada.

What's happening

Ceftriaxone is currently affected by an active shortage report filed with Health Canada by FRESENIUS KABI CANADA LTD.

The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ceftriaxone is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DD).

Recent changes

Common questions

When will Ceftriaxone be back in stock in Canada?

The latest manufacturer estimate is Jun 15, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ceftriaxone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other beta-lactam antibacterials)

All other beta-lactam antibacterials shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.